Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Narang · SciRah

Researcher profile · Semantic Scholar

M. Narang

Share profile

M. Narang — researcher profile on SciRah

h-index: 17
Works: 112
Citations: 789

Most-cited papers

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes
J. Shah, R. Abonour, C. Gasparetto, J. Hardin +7 more
2017Clinical Lymphoma, Myeloma & Leukemia94 citations
Semantic Scholar
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study
H. Yimer, J. Melear, E. Faber, W. Bensinger +10 more
2019British Journal of Haematology67 citations Open access
Semantic Scholar
Recognition of early mortality in multiple myeloma by a prediction matrix
H. Terebelo, S. Srinivasan, M. Narang, R. Abonour +7 more
2017American journal of hematology/oncology44 citations Open access
Semantic Scholar
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry
R. Abonour, L. Wagner, B. Durie, S. Jagannath +10 more
2018Annals of Hematology40 citations Open access
Semantic Scholar
Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA® registry
D. Grinblatt, M. Sekeres, R. Komrokji, A. Swern +2 more
2015Leukemia and Lymphoma39 citations
Semantic Scholar
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM.
S. Jagannath, R. Abonour, B. Durie, M. Narang +11 more
2018Blood Advances35 citations Open access
Semantic Scholar
Heterogeneity of Second‐Line Treatment for Patients With Multiple Myeloma in the Connect MM Registry (2010–2016)
S. Jagannath, R. Abonour, B. Durie, C. Gasparetto +11 more
2018Clinical Lymphoma, Myeloma & Leukemia33 citations Open access
Semantic Scholar
Connect MM® – the Multiple Myeloma Disease Registry: incidence of second primary malignancies in patients treated with lenalidomide
R. Rifkin, R. Abonour, J. Shah, J. Mehta +11 more
2016Leukemia and Lymphoma28 citations Open access
Semantic Scholar
Association between race and treatment patterns and survival outcomes in multiple myeloma: A Connect MM Registry analysis
S. Ailawadhi, S. Jagannath, Hans C. Lee, M. Narang +13 more
2020Cancer25 citations Open access
Semantic Scholar
Connect MM Registry as a national reference for United States multiple myeloma patients
S. Ailawadhi, S. Jagannath, M. Narang, R. Rifkin +12 more
2019Cancer Medicine21 citations Open access
Semantic Scholar
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
C. Gasparetto, S. Jagannath, R. Rifkin, B. Durie +13 more
2021Clinical Lymphoma, Myeloma & Leukemia19 citations Open access
Semantic Scholar
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM Registry.
S. Jagannath, R. Rifkin, C. Gasparetto, K. Toomey +14 more
2019Clinical Lymphoma, Myeloma & Leukemia19 citations Open access
Semantic Scholar
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
Hans C. Lee, S. Ailawadhi, C. Gasparetto, S. Jagannath +12 more
2021Blood Cancer Journal18 citations Open access
Semantic Scholar
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study
H. Yimer, J. Melear, E. Faber, W. Bensinger +11 more
2022Leukemia and Lymphoma17 citations Open access
Semantic Scholar
Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient Registry
H. Terebelo, R. Abonour, Cristina J. Gasparetto, K. Toomey +11 more
2019British Journal of Haematology17 citations Open access
Semantic Scholar
Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Any or Lenalidomide Maintenance after Autologous Stem Cell Transplant in the Connect® MM Disease Registry
R. Abonour, B. Durie, S. Jagannath, J. Shah +10 more
201614 citations
Semantic Scholar
Treatment Outcomes and Health Care Resource Utilization in Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide-only Maintenance, Any Maintenance, or No Maintenance: Results from the Connect MM Registry.
R. Rifkin, S. Jagannath, B. Durie, M. Narang +11 more
2018Clinical Therapeutics13 citations Open access
Semantic Scholar
Lyra: A Phase 2 Study of Daratumumab (Dara) Plus Cyclophosphamide, Bortezomib, and Dexamethasone (Cybord) in Newly Diagnosed and Relapsed Patients (Pts) with Multiple Myeloma (MM)
H. Yimer, J. Melear, E. Faber, W. Bensinger +10 more
2018Blood12 citations
Semantic Scholar
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry.
Hans C. Lee, K. Ramasamy, K. Weisel, R. Abonour +16 more
2022Clinical Lymphoma, Myeloma & Leukemia10 citations Open access
Semantic Scholar
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices
R. Rifkin, J. Crawford, R. Mahtani, D. Dale +8 more
2022Supportive Care in Cancer10 citations Open access
Semantic Scholar
Iron deficiency anemia in patients with heavy menstrual bleeding: The patients’ perspective from diagnosis to treatment
Imo J. Akpan, M. Narang, E. Zampaglione, Steve Marshall +1 more
2025Women's Health9 citations Open access
Semantic Scholar
Daratumumab (DARA) Maintenance Therapy Improves Depth of Response and Results in Durable Progression-Free Survival (PFS) Following Dara Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) Induction Therapy in Multiple Myeloma (MM): Update of the Lyra Study
R. Rifkin, J. Melear, E. Faber, W. Bensinger +10 more
2019Blood8 citations Open access
Semantic Scholar
Effect of initial treatment on health‐related quality of life in patients with newly diagnosed multiple myeloma without immediate stem cell transplant intent: results from the Connect® MM Registry
R. Abonour, R. Rifkin, C. Gasparetto, K. Toomey +12 more
2020British Journal of Haematology7 citations Open access
Semantic Scholar
Impact of t(11;14) on outcomes in African American (AA) and non-AA (NAA) patients (Pts) with newly diagnosed multiple myeloma (NDMM): Connect MM registry.
C. Gasparetto, R. Abonour, S. Jagannath, B. Durie +12 more
20177 citations
Semantic Scholar
Optimization studies on the development of a blended fruit nectar based upon papaya (Carica papaya) and bottle gourd (Lagenaria siceraria)
B. Yadav, Ritika B. Yadav, M. Narang
20137 citations
Semantic Scholar
A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis
R. Mahtani, R. Belani, J. Crawford, D. Dale +8 more
2022Supportive Care in Cancer6 citations Open access
Semantic Scholar
Treatment Patterns from 2009 to 2015 in Patients with Newly Diagnosed Multiple Myeloma in the United States: A Report from the Connect® MM Registry
R. Rifkin, R. Abonour, B. Durie, C. Gasparetto +9 more
20166 citations
Semantic Scholar
Therapeutic Response to Azacitidine (AZA) In Patients with Secondary Myelodysplastic Syndromes (sMDS) Enrolled In the AVIDA Registry
M. Sekeres, M. Narang, R. Komrokji, J. Maciejewski +5 more
20106 citations
Semantic Scholar
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer
B. Besse, V. Subbiah, G. Curigliano, Daniel W. Bowles +27 more
2026Journal of Clinical Oncology5 citations Open access
Semantic Scholar
Treatment Patterns From 2009-2015 in Patients With Newly Diagnosed Multiple Myeloma in the United States: A Report From the Connect® MM Registry
R. Rifkin, R. Abonour, B. Durie, C. Gasparetto +9 more
20175 citations
Semantic Scholar
Characteristics and Treatment Patterns of Long-surviving Patients With Multiple Myeloma: Over 13 Years of Follow-up in the ConnectⓇ MM Registry.
H. Terebelo, J. Omel, L. I. Wagner, J. Hardin +13 more
2024Clinical Lymphoma, Myeloma & Leukemia4 citations Open access
Semantic Scholar
Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States
J. Castillo, E. Kingsley, M. Narang, H. Yimer +9 more
2023eJHaem4 citations Open access
Semantic Scholar
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
S. Ailawadhi, Hans C. Lee, J. Omel, K. Toomey +12 more
2024Blood Cancer Journal3 citations Open access
Semantic Scholar
Real-World Treatment Patterns and Clinical, Economic, and Humanistic Burden in Triple-Class Refractory Multiple Myeloma: Analysis of the Connect ® Multiple Myeloma (MM) Disease Registry
D. Tang, P. Hari, K. Ramasamy, K. Weisel +16 more
2021Blood3 citations Open access
Semantic Scholar
Health-Related Quality of Life Assessments Predict Relapse or Death in Patients with Newly Diagnosed Multiple Myeloma (MM): Results from the Connect® MM Registry
I. Wagner, B. Durie, Sundar Jagannath, M. Narang +11 more
20183 citations Open access
Semantic Scholar
Connect MM®—the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease
J. Shah, R. Abonour, B. Durie, J. Mehta +10 more
20143 citations
Semantic Scholar
An examination of educational gaps in the diagnosis and treatment of myelodysplastic syndromes.
J. Shammo, J. Foran, A. Houk, J. Epstein +5 more
2011Cancer Control: Journal of the Moffitt Cancer Cente3 citations Open access
Semantic Scholar
A study on Cyber-attack detection in IoMT using Machine Learning Techniques
M. Narang, A. Jatain, Nirmal Punetha
2023Social Science Research Network2 citations Open access
Semantic Scholar
Impact of lenalidomide-bortezomib-dexamethasone (RVd) induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect MM Registry.
S. Ailawadhi, Hans C. Lee, J. Omel, K. Toomey +14 more
2020Journal of Clinical Oncology2 citations
Semantic Scholar
Clinical Features and Survival Outcomes in Diabetic Patients with Newly Diagnosed Multiple Myeloma (NDMM) Enrolled in the Connect® MM Registry
Lisa La, S. Jagannath, S. Ailawadhi, B. Durie +14 more
2020Blood2 citations Open access
Semantic Scholar
Effect of t(11;14) on outcomes of patients (pts) with newly diagnosed multiple myeloma (NDMM) in the connect MM registry.
C. Gasparetto, S. Jagannath, R. Rifkin, B. Durie +13 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
Treatment (tx) journeys in newly diagnosed multiple myeloma (NDMM) patients (pts): Results from the Connect MM Registry.
S. Jagannath, R. Rifkin, C. Gasparetto, K. Toomey +13 more
20182 citations
Semantic Scholar
Treatment Choices and Outcomes for Patients with Multiple Myeloma after Relapse on Lenalidomide Maintenance Therapy: Results from the Connect® MM Registry
S. Jagannath, M. Narang, S. Ailawadhi, R. Rifkin +11 more
2018Blood2 citations Open access
Semantic Scholar
Impact of post-autologous stem cell transplant (ASCT) maintenance therapy on outcomes in patients (Pts) with newly diagnosed multiple myeloma (NDMM) using the large prospective community-based Connect MM registry.
S. Jagannath, R. Abonour, B. Durie, J. Shah +12 more
20172 citations
Semantic Scholar
Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)
R. Rifkin, R. Abonour, J. Shah, J. Mehta +12 more
20142 citations
Semantic Scholar
Early mortality (EM) for newly diagnosed multiple myeloma (NDMM) in the Connect MM U.S. registry.
H. Terebelo, J. Shah, B. Durie, R. Abonour +13 more
20132 citations
Semantic Scholar
Connect MM: The multiple myeloma (MM) disease registry—Incidence of second primary malignancies (SPM).
R. Rifkin, R. Abonour, R. Fonseca, C. Gasparetto +12 more
20122 citations
Semantic Scholar
155 Health-related quality of life by RBC transfusion dependence (TD) or independence (TI) of patients (Pts) initiating treatment for MDS
C. Pashos, D. Grinblatt, M. Sekeres, R. Komrokji +5 more
20112 citations
Semantic Scholar
Association of Changes in Transfusion Status with Changes in Health-Related Quality of Life of Real-World Patients with MDS Across Six Months of Treatment with Azacitidine
C. Pashos, D. Grinblatt, M. Sekeres, R. Komrokji +6 more
20112 citations
Semantic Scholar
Optec/Optal: A phase 2 study to evaluate outpatient (OP), step-up administration of teclistamab (Tec) or talquetamab (Tal) with prophylactic tocilizumab (prophyToci) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
Peter A. Forsberg, D. Andorsky, Robert Rifkin, Christopher Yasenchak +15 more
2026Journal of Clinical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Rifkin×39
Invite
R. Rifkin — researcher profile on SciRah
R. Abonour×33
Invite
R. Abonour — researcher profile on SciRah
K. Toomey×33
Invite
K. Toomey — researcher profile on SciRah
H. Terebelo×32
Invite
H. Terebelo — researcher profile on SciRah

×31

Invite

B. Durie — researcher profile on SciRah

C. Gasparetto×29

Invite

C. Gasparetto — researcher profile on SciRah

Invite

J. Hardin — researcher profile on SciRah

S. Srinivasan×25

Invite

S. Srinivasan — researcher profile on SciRah

S. Jagannath×23

Invite

S. Jagannath — researcher profile on SciRah

Amani Kitali×19

Invite

Amani Kitali — researcher profile on SciRah

Invite

L. Wagner — researcher profile on SciRah

Invite

A. Agarwal — researcher profile on SciRah